Janssen v. Celltrion Appeal Docketed

Janssen v. Celltrion (infliximab)

The appeal from Janssen Biotech, Inc. v. Celltrion Healthcare Co. (D. Mass. No. 15-10698) has been docketed at the Federal Circuit with the number 17-1120.  Janssen’s opening brief is due on December 27, 2016.  We have posted extensively on the district court case, most recently here, and will continue to post on all updates with the appeal.

Download PDF

Tagged with 

Comments are closed.